ClearPoint Neuro (CLPT) EV/EBITDA: History & Chart

ClearPoint Neuro, Inc.(CLPT)

Medical - Devices · Solana Beach, CA

$11.16-0.36 (-3.12%)

Delayed quote: Oct 6, 2026, 11:25 AM EDT

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Solana Beach, CA

172 employees

www.clearpointneuro.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joseph Michael Burnett

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
ClearPoint Neuro, Inc. (CLPT)	$334.68M	N/A	N/A	N/A	N/A
Cabaletta Bio, Inc. (CABA)vs ›	$333.45M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$342.30M	8.90x	20.16x	20.16x	12.62x
C4 Therapeutics, Inc. (CCCC)vs ›	$323.41M	N/A	N/A	N/A	N/A
CapsoVision, Inc. (CV)vs ›	$323.01M	N/A	N/A	N/A	N/A
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$348.59M	N/A	N/A	N/A	N/A
Orchestra BioMed Holdings, Inc. (OBIO)vs ›	$354.49M	N/A	N/A	N/A	N/A
Embecta Corp. (EMBC)vs ›	$355.67M	5.38x	4.73x	7.57x	7.31x
Fennec Pharmaceuticals Inc. (FENC)vs ›	$356.36M	N/A	40.38x	40.38x	40.38x
Enanta Pharmaceuticals, Inc. (ENTA)vs ›	$356.50M	N/A	37.95x	29.61x	22.14x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

ClearPoint Neuro, Inc. (CLPT)

$334.68M

N/A

Cabaletta Bio, Inc. (CABA)vs ›

$333.45M

N/A

Agenus Inc. (AGEN)vs ›

$342.30M